A new technique which slashes the time taken to diagnose microbial infections from days to minutes could help save lives and ...

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Atea Pharmaceuticals, Inc. Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026 ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use ...

Copperfield Lane will be aglow with dazzling lights, music and treats this weekend. One family is putting on a free holiday display as a gift to the entire community. There's still time to vote for ...

Assay demonstrated a 100% positive percent agreement and negative percent agreement compared with commercial platforms. HealthDay News — A rapid, highly accurate test has been developed for diagnosing ...

The Research Use Only DASH HCV assay had a wide dynamic range, was able to detect HCV genotypes 1 to 6, and demonstrated a detection limit of 200 IU/mL with the addition of 100 µL of specimen volume.

Instead of recommending the hepatitis B vaccine for all newborns, the Centers for Disease Control and Prevention now officially advises women who test negative for the virus to consult health care ...